Hypothesis

Age-related NAD+ decline in CeA‑CRF neurons is not a passive loss but an adaptive downregulation that protects these cells from calcium‑induced excitotoxicity by increasing SIRT3 activity, which deacetylates and inhibits the mitochondrial calcium uniporter (MCU). While this safeguards neuronal survival, it concurrently blunts activity‑dependent BDNF transcription and synaptic plasticity needed for fear extinction.

Mechanistic Rationale

NAD+ fuels SIRT3, a mitochondrial deacetylase that removes acetyl groups from MCU subunits, reducing channel open probability and limiting calcium influx during high‑frequency firing【https://pmc.ncbi.nlm.nih.gov/articles/PMC6787556/】. Lower MCU activity diminishes mitochondrial calcium overload, a known trigger of CRF neuron hyperexcitability after early‑life stress【https://www.frontiersin.org/journals/behavioral-neuroscience/articles/10.3389/fnbeh.2025.1653346/full】. However, MCU‑mediated calcium spikes also activate calcium‑dependent kinases (CaMKIV) that drive CREB‑dependent BDNF expression, a key modulator of extinction learning【https://pmc.ncbi.nlm.nih.gov/articles/PMC3259347/】. Thus, NAD+‑driven SIRT3 activation creates a trade‑off: reduced excitotoxic risk at the expense of plasticity‑supporting calcium signaling.

Testable Predictions

1. Aged mice will show elevated SIRT3 activity and decreased MCU acetylation in CeA‑CRF neurons compared with young adults.
2. Genetic or pharmacological inhibition of SIRT3 in these neurons will increase MCU acetylation, raise mitochondrial calcium uptake, and restore fear extinction without altering baseline anxiety.
3. Conversely, overexpressing a deacetylation‑resistant MCU mutant will mimic the effects of NAD+ loss, impairing extinction even when NAD+ levels are supplemented.
4. Systemic NAD+ boosters (e.g., NR) will improve extinction only when SIRT3 is concurrently knocked down in CRF cells, indicating that the benefit of NAD+ repletion depends on modulating the SIRT3‑MCU axis.

Experimental Design

• Use CRF‑Cre mice crossed with AAV‑flex‑shSIRT3 or AAV‑flex‑SIRT3 overexpression vectors targeted to the CeA.
• Measure mitochondrial calcium flux with mito‑GCaMP6f in slice preparations during optogenetic CRF neuron stimulation.
• Assess MCU acetylation by immunoprecipitation followed by Western blot with acetyl‑lysine antibodies.
• Evaluate fear extinction using contextual fear conditioning followed by extinction trials; quantify freezing and calculate extinction indices.
• Perform rescue experiments with nicotinamide riboside (NR) supplementation ± SIRT3 knockdown.
• Include controls: scrambled shRNA, empty vector, and wild‑type littermates.

Potential Implications

If validated, this hypothesis reframes NAD+ decline as a circuit‑specific protective adjustment that becomes maladaptive for cognitive flexibility. It suggests that precision interventions—modulating SIRT3 or MCU activity in CRF neurons—could rescue extinction deficits while preserving any systemic advantages of NAD+ conservation. Such an approach avoids the pitfalls of global NAD+ elevation, which might inadvertently exacerbate excitotoxic stress in vulnerable networks.